12-hydroxy-5,8,10-heptadecatrienoic acid and Thrombocytopathy

12-hydroxy-5,8,10-heptadecatrienoic acid has been researched along with Thrombocytopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Vliet, H; Vincent, JE; Zijlstra, FJ1

Other Studies

1 other study(ies) available for 12-hydroxy-5,8,10-heptadecatrienoic acid and Thrombocytopathy

ArticleYear
Determination of the formation of thromboxane B2 (TxB2), 12L-hydroxy-5,8,10 heptadecatrienoic acid (HHT) and 12L-hydroxy-5,8,10,14 eicosatrienoic acid (HETE) from arachidonic acid and of the TxB2 :HHT, TxB2 :HETE and (TxB2 +HHT) :HETE ratio in human plate
    Prostaglandins and medicine, 1980, Volume: 5, Issue:2

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acids; Blood Platelet Disorders; Blood Platelets; Fatty Acids, Unsaturated; Humans; Hydroxy Acids; Male; Thromboxane B2; Thromboxanes

1980